Business Wire

ALIEN-WORLDS

28.3.2022 15:11:05 CEST | Business Wire | Press release

Share
Minecraft Gamers Can Now Earn Trilium From the Alien Worlds Metaverse

Minecraft , the best-selling video game in history engaging more than 170 million players, will be able to earn Trilium, the native cryptocurrency in the Alien Worlds metaverse. Alien Worlds is one of the largest play to earn (P2E) blockchain games and NFT metaverse.

Launched in 2020, Alien Worlds has grown to be the second largest blockchain platform by monthly active users. In the game, users can play with unique digital items (NFTs), stake Trilium tokens, travel on Alien Worlds Missions to other planets, vote in elections, and run for planetary council. The game’s 6 planet DAOs compete with each other for Trilium, encouraging user collaboration.

The new interoperability bridge to the world’s longest running and most popular online building platform will have resounding effects in the traditional and blockchain gaming worlds. The bridge will accelerate the onboarding of non-blockchain gamers onto the Alien Worlds metaverse, and also due to the open sourced nature of the code developed - empower other Minecraft servers to earn play-to-earn rewards. Plus, it will allow other blockchain projects to tap into Minecraft's vast user base.

Additionally, this interoperability will offer traditional gamers the opportunity to earn assets, in this case Trilium, and soon NFTs, for completing quests. Players are able to exchange their digital assets freely, enabling them to earn real world utility by getting involved in Alien Worlds’ simulated economy.

“This bridge is significant in that we are linking one of the world’s most popular decentralized games to the blockchain, and opening up a world of new possibilities for Minecraft players through our social metaverse,” says Alien Worlds co-founder Saro McKenna. “We think our combination of economics, team strategy and earning will convert Minecraft players of all ages into Web3 players.”

Additionally, earning Trilium will allow Minecraft gamers to stake the fungible token to one of the Alien Worlds Planet DAOs, which hold some of the largest treasuries in the space. Staked Trilium translates into voting power to determine control of planetary treasuries. Minecraft players will not only be able to learn about DAOs, but also to participate in the collaborative, competitive and highly strategic environment that their gamification entails.

About Alien Worlds

Alien Worlds is a breakthrough NFT Metaverse and one of the world’s most popular play-to-earn blockchain games, where users can play with unique digital assets (NFTs), stake Trilium tokens, travel on Missions to the planets, vote in elections, and run for planetary council. The game’s 6 planet DAOs compete with each other for Trilium, allowing users to collaborate, compete and strategize with one another.

With almost 7 million all-time players and more than 700,000 Monthly Active Users (number of unique wallet addresses interacting with Alien Worlds' smart contracts on a monthly basis, DappRadar ), Alien Worlds has rapidly climbed the DappRadar ranking charts and inspired individuals to scale new heights of imagination in order to create, share and thrive in the Social Metaverse.

To access and play Alien Worlds and the new Alien Worlds Missions game, visit www.alienworlds.io , play.alienworlds.io/missions and the Explorers Station .

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye